## 

|CONTENTS|||PAGES|
|---|---|---|---|
|Directors' Report|||1-7|
|Independent|Auditors'|Report|8- 10|
|Statement of|Financial|Activities||
|Balance Sheet|||12|
|Statement of|Cash Flows||13|
|Notes forming|part of|the Financial Statements|14-18|





## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

||FOR|THE YEAR END|ED 31 MARCH|2023|||
|---|---|---|---|---|---|---|
|||Notes|Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2023|2022|
||||6|F|6|6|
|Income from:|||||||
|Donations<br>and grants||2|539,364|75,462|614,826|514,671|
|Charitable<br>activities||3|5,655||5,655|227|
|Other|||104||104||
|Investments - Bank interest|||4||4||
|Total|||545,127|75,462|620,589|514,900|
|Expenditure<br>on:|||||||
|Charitable<br>activities||4|545,027|75,462|620,489|514,800|
|Net income/(expenditure)||8|100||100|100|
|Transfers<br>between|funds||||||
|Net movement<br>in|funds|14|100||100|100|
|Reconciliation<br>of|funds||||||
|Total funds bought|forward|14|410||410|310|
|Total funds canted forward||14|9510|ENil|6510|F410|





## 

||||||Notes|2023|2022|
|---|---|---|---|---|---|---|---|
|||||||6|f|
|CURRENT ASSETS||||||||
|Debtors|||||12|59,088|20,906|
|Cash at bank||and|in|hand||2,815|2,441|
|||||||61,903|23,347|
|CREDITORS:||Amounts||falling due||||
|within one|year||||13|61,393|22,937|
|NET ASSETS||||||8510|6410|
|Represented|by:|||||||
|FUNDS||||||||
|Restricted|Funds||||14|||
|Unrestricted||Funds|||14|510|410|
|||||||F510|6410|





## 

## 

## 

|||||2023<br>f|2022<br>8|
|---|---|---|---|---|---|
|Cash flows from operating<br>activities||||||
|Net movement<br>in funds per statement<br>of|financial||activities|||
|Adjustments<br>for.||||||
|Investment<br>income - Interest receivable||||(4)|(2)|
|(Increase) Idecrease<br>in debtors||||(38,182)|15,095|
|Increase I (decrease)<br>in creditors||||38,456|(14,943)|
|Net cash provided by /(used In) operating||activides||370|250|
|Cash flows from investing<br>activities||||||
|Investment<br>income - Interest received||||||
|Net cash provided by investing<br>activities||||||
|Change<br>in cash and cash equivalents|in the year|||374|252|
|Cash and cash equivalents<br>brought<br>forward|||||2,189|
|Cash and cash equivalents<br>carried forward||||F2,815|E2,441|
|Analysis ofcash and cash equivalents||||2023|2022|
|Cash at bank and<br>in hand||||K2,815||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 


|||lcontd. ..||||
|---|---|---|---|---|---|
|DONATIONS|AND GRANTS|Unrestricted|Restricted|Total|Total|
|||funds<br>F|Funds<br>f|2023<br>6|2022|
|Grants||||||
|Alliance House Foundation||539,364||539,364|44'I,259|
|Cancer Research<br>UK|||29,110|29,110|25,440|
|World Health|Organisation||||10,206|
|Institute ofSocial Marketing|||3,000|3,000|4,608|
|British Academy Research Project|||9,400|9,400||
|Health<br>Lumen|||||6,569|
|Alcohol Health|Alliance||10,000|10,000|16,589|
|Donations||||||
|Alcohol Health|Alliance||23,952|23,952|10,000|
|||F539,364|675,462|6614,826|8514,671|



||Of the 6514,671 recognised<br>in <br>restricted funds.|Of the 6514,671 recognised<br>in <br>restricted funds.|Of the 6514,671 recognised<br>in <br>restricted funds.|2022, F441|,259 related<br>to un|restricted<br>fu|nds<br>and 673,|412 related|
|---|---|---|---|---|---|---|---|---|
|3.|INCOME FROM CHARITABLE|||ACTIVITIES|Unrestricted|Restricted|Total|Total|
||||||funds<br>f|funds<br>6|2023<br>6|2022<br>f|
||Alcohol Conference|Arrangement||Fee|5,605||5,605||
||Sundry<br>Income||||50||50|227|
||||||65,655|6Nil|25,655|F227|
||All ofthe 6227 recognised||in 2022 related to||unrestricted<br>funds.||||
|4.|EXPENDITURE ON|CHARITABLE|||Direct|Support|Total|Total|
||ACTIVITIES||||costs|costs|2023|2022|
||Research and dissemination||||f464,438|6156,051|f620,489|F514,800|



|Of the 6514,800 expenditure<br>recognised<br>in 2022, F4<br>673,512was charged to restricted funds.|Of the 6514,800 expenditure<br>recognised<br>in 2022, F4<br>673,512was charged to restricted funds.|Of the 6514,800 expenditure<br>recognised<br>in 2022, F4<br>673,512was charged to restricted funds.|Of the 6514,800 expenditure<br>recognised<br>in 2022, F4<br>673,512was charged to restricted funds.|41,288 was<br>charged<br>to unrestrict|ed<br>funds<br>a|
|---|---|---|---|---|---|
|ANALYSIS OF DIRECT COSTS||||2023|2022|
||||||8|
|Wages|and salaries|||405,845|362,655|
|Advisory|panel|||7,000|7,000|
|Travel,|conferences||and symposia|6,595|2,832|
|Website|redesign|and development|||100|
|Media Monitoring||||4,275|3,968|
|Publications<br>and||subscriptions||40,723|13,712|
|||||f464,438|F390,287|





## 

## 

## 

## 

## 

|||||
|---|---|---|---|
|ANALYSIS OF SUPPORT COST|S|2023<br>E|2022f|
|Wages and salaries||15,906|10,996|
|Staff training<br>and recruitment||2,905|5,071|
|Office rent &service charge||88,741|70,566|
|Office costs||25,930|18,859|
|IT and computer costs||18,845|17,001|
|Governance<br>costs (see Note 7)||3,724|2,040|
|||F156,051|8124,533|
|GOVERNANCE COSTS||2023|2022|
|||f.|8|
|Audit fees and related costs||948|2,040|
|Directors'<br>meetings||2,776||
|||53,724||
|NET INCOME/(EXPENDITURE)|FOR THE YEAR|2023|2022|
|This is stated after charging:<br>Auditor's<br>remuneration<br>—audit services||f978|E2,040|
|STAFF COSTS AND NUMBERS||2023|2022|
|||5|E|
|Salaries||340,248|305,630|
|Social security costs||32,443|29,709|
|Pension costs||48,690|37,783|
|Other costs||370|529|
|||8421,751|2373,651|



## 



## 

## 

## 

## 

|12.|DEBTORS||||||2023|2022|
|---|---|---|---|---|---|---|---|---|
||Prepayments|and|other debtors||||659,088|820,906|
|13.|CREDITORS:|Amounts<br>falling due||within one year|||2023|2022|
||||||||6|5|
||Accruals||||||3,364|5,320|
||Other creditors||||||58,029|17,617|
||||||||661,393|822,937|
|14.|RESERVES|||Balance||||Balance|
|||||at||||at|
|||||1 April||||31 March|
||2023|||2022|Income|Expenditure|Transfers|2023|
||Restricted funds||||||||
||Alcohol Health|Alliance Project|||33,952|33,952|||
||Cancer Research||UK||29,110|29,110|||
||British Academy||Research Project||9,400|9,400|||
||Institute ofSocial||Marketing||3,000|3,000|||
||||||75,462|75,462|||
||Unrestricted|Funds|||||||
||General funds|||410|545,127|545,027||510|
|||||f410|6545,127|f545,027|6Nil|6510|





## 

## 

## 

## 

## 

|Compar|ative<br>infor|mation<br>for the pre|vious<br>financial|year is as fo|llows:|||
|---|---|---|---|---|---|---|---|
||||Balance at||||Balance at|
||||1 April||||31 March|
|2022|||2021|income|Expenditure|Transfers|2022|
|Restricted funds||||||||
|Alcohol|Health Alliance Project|||26,589|26,589|||
|Cancer|Research|UK||25,440|25,440|||
|World Health Organisation||||10,206|10,206|||
|Institute|ofSocial|Marketing||4,608|4,608|||
|Health|Lumen|||6,569|6,569|||
|Alliance|House Foundation||100||100|||
|||||73,412|73,512|||
|Unrestricted<br>Funds||||||||
|General|funds||210|441,488|441,288||410|
||||8310|8514,900|F514,800|ENII|F410|
|RELATED PARTY TRANSACTIONS||||||||
|Details|of related|party transactions|during<br>the year are as follows:|||||
|Name of related||party|Nature of|Transaction||||
||||relationship|details||Amount|Balance|
|||||||E||
|2023||||||||
|Alliance|House Foundation||Connected|Grant||||
||||charity|funding||539,364|(28,290)|
|Alliance|House Foundation||Connected|Rent||||
||||charity|payable||63,500||
|2022||||||||
|Alliance|House Foundation||Connected|Grant||||
||||charity|funding||441,259|8,589|
|Alliance|House Foundation||Connected|Rent||||
||||charity|payable||54,637||



## 

